|
0
|
1 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a SUNITINIB TEND
|
|
|
2 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a IMATINIB TEND
|
|
|
3 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB MyCancerGenome
|
|
|
4 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB MyCancerGenome
|
|
|
5 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SORAFENIB MyCancerGenome
|
|
|
6 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB MyCancerGenome
|
|
|
7 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB MyCancerGenome
|
|
|
8 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB MyCancerGenome
|
|
|
9 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB MyCancerGenome
|
|
|
10 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB TALC
|
|
|
11 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB TALC
|
|
|
12 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB TALC
|
|
|
13 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB TALC
|
|
|
14 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB TALC
|
|
|
15 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor LENVATINIB TALC
|
|
|
16 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB TALC
|
|
|
17 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AT9283 TALC
|
|
3
|
18 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationClinicalTrial
|
|
|
19 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a DOVITINIB ClearityFoundationClinicalTrial
|
|
0
|
20 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AEG40826 TALC
|
|
|
21 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist TL 32711 TALC
|
|
|
22 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AT-406 TALC
|
|
|
23 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist GDC0917 TALC
|
|
|
24 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist LCL161 TALC
|
|
3
|
25 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a E7449 ClearityFoundationBiomarkers
|
|
|
26 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a NIRAPARIB ClearityFoundationBiomarkers
|
|
|
27 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a OLAPARIB ClearityFoundationBiomarkers
|
|
|
28 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a BMN673 ClearityFoundationBiomarkers
|
|
|
29 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a RUCAPARIB ClearityFoundationBiomarkers
|
|
|
30 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a VELIPARIB ClearityFoundationBiomarkers
|
|
|
31 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationBiomarkers
|
|
|
32 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a EVEROLIMUS ClearityFoundationBiomarkers
|
|
|
33 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TEMSIROLIMUS ClearityFoundationBiomarkers
|
|
|
34 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GDC-0973 ClearityFoundationBiomarkers
|
|
|
35 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a MEK162 ClearityFoundationBiomarkers
|
|
|
36 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PD-325901 ClearityFoundationBiomarkers
|
|
|
37 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a RAFAMETINIB ClearityFoundationBiomarkers
|
|
|
38 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a SELUMETINIB ClearityFoundationBiomarkers
|
|
|
39 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TRAMETINIB ClearityFoundationBiomarkers
|
|
|
40 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a CETUXIMAB ClearityFoundationBiomarkers
|
|
|
41 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a ERLOTINIB ClearityFoundationBiomarkers
|
|
|
42 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GEFITINIB ClearityFoundationBiomarkers
|
|
|
43 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PANITUMUMAB ClearityFoundationBiomarkers
|
|
|
44 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PIMASERTIB ClearityFoundationBiomarkers
|
|
0
|
45 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE inhibitor REOLYSIN CancerCommons
|
|
|
46 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE vaccine RAS PEPTIDE CANCER VACCINE TALC
|
